Bio-Rad Laboratories
American life science research firm
BIO NYSE
SEC CIK 12208 LEI 549300ZC1GPV35XYDK53
Follow Bio-Rad Laboratories
Weekly email: filings, results
Revenue, last quarter
$656.4M
+0.5% vs same quarter last year
Net income
$458.6M
+234.1% vs same quarter last year
EPS, diluted
$17.02
+234% vs same quarter last year
Operating cash flow
$96.4M
−20.3% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $2.6B | $759.9M |
| FY24 | $2.6B | −$1.8B |
| FY23 | $2.7B | −$637.3M |
| FY22 | $2.8B | −$3.6B |
| FY21 | $2.9B | $4.3B |
| FY20 | $2.5B | $3.8B |
| FY19 | $2.3B | $1.8B |
| FY18 | $2.3B | $365.6M |
| FY17 | $2.2B | $122.2M |
| FY16 | $2.1B | $26M |
| FY15 | $2B | $109.2M |
| FY14 | $2.2B | $88.8M |
| FY13 | $2.1B | $77.8M |
| FY12 | $2.1B | $165.5M |
| FY11 | $2.1B | $179M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 51.9% | 1.8% | 29.4% |
| FY24 | 53.7% | 10.5% | −71.9% |
| FY23 | 53.4% | 12.6% | −23.9% |
| FY22 | 55.9% | 17.2% | −129.5% |
| FY21 | 56.1% | 17.1% | 145.6% |
| FY20 | 56.5% | 16.6% | 149.8% |
| FY19 | 54.4% | 9.9% | 76.1% |
| FY18 | 53.4% | −4.5% | 16% |
| FY17 | 55% | 5.5% | 5.7% |
| FY16 | 55% | 2.7% | 1.3% |
| FY15 | 55.5% | 8.3% | 5.4% |
| FY14 | 54.2% | 6.9% | 4.1% |
| FY13 | 55.3% | 7.9% | 3.6% |
| FY12 | 55.8% | 12.8% | 8% |
| FY11 | 56.9% | 14.7% | 8.6% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $374.6M |
| FY24 | $289.6M |
| FY23 | $218.2M |
| FY22 | $81.6M |
| FY21 | $535.7M |
| FY20 | $476.4M |
| FY19 | $359.4M |
| FY18 | $155.7M |
| FY17 | −$7.2M |
| FY16 | $74.6M |
| FY15 | $74.2M |
| FY14 | $152.3M |
| FY13 | $62.5M |
| FY12 | $123.6M |
| FY11 | $159.8M |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | $295.5M |
| FY24 | $203.6M |
| FY23 | $428.7M |
| FY22 | $215.7M |
| FY21 | $50M |
| FY20 | $100M |
| FY19 | $28M |
| FY18 | $48.9M |
| FY17 | $2.9M |
| FY16 | $0 |
| FY15 | $0 |
| FY14 | $0 |
| FY13 | $0 |
| FY12 | $101K |
| FY11 | $0 |
- Bio-Rad Laboratories
- Technology median
Show the numbers
| Year | Bio-Rad Laboratories | Technology median |
|---|---|---|
| FY25 | 29.4% | −2.3% |
| FY24 | −71.9% | −5% |
| FY23 | −23.9% | −6.7% |
| FY22 | −129.5% | −4.4% |
| FY21 | 145.6% | −1.7% |
| FY20 | 149.8% | −3% |
| FY19 | 76.1% | 0% |
| FY18 | 16% | 0.8% |
| FY17 | 5.7% | 2% |
| FY16 | 1.3% | 2.3% |
| FY15 | 5.4% | 3.1% |
| FY14 | 4.1% | 2.9% |
| FY13 | 3.6% | 3.9% |
| FY12 | 8% | 3.9% |
| FY11 | 8.6% | 5.7% |